all report title image
  • Published On : Aug 2022
  • Code : CMI5186
  • Industry : Biotechnology
  • Pages : 160
  • Formats :

Omics is a term brief for various diverse studies which includes genomics, transcriptomics, proteomics and metabolomics. The traditional transcriptomics and proteomics approaches have provided insight into disease progression by identifying discrete cellular subpopulation or micro environmental signatures characteristics of normal or pathological tissues. The spatial pattern of the genome have been identified for the treatment of various diseases because of that spatial information is being used as a diagnostic biomarker for identifying the medical condition. Special omics combines molecular analysis with spatial information on the cells localization within the tissue. Thus, this technology is providing a powerful tool to understand important mechanisms such as tissue organisation or cell regulation.

The global spatial omics market is estimated to be valued at US$ 267 million in 2022 and is expected to exhibit a CAGR of 9.4 % over the forecast period (2022-2030)

Figure 1. Global Spatial Omics Market Value (US$ Mn), By Region, 2022

Spatial Omics  | Coherent Market Insights

Increasing cancer population worldwide is expected to drive growth of the global spatial omics market over the forecast period.

For instance, according to World Health Organisation, cancer is a leading cause of death worldwide, accounting for nearly 10 million deaths in 2020. There were 1.41 million cases of prostate cancer worldwide.

CMI table icon

Spatial Omics Market Report Coverage

Report Coverage Details
Base Year: 2021 Market Size in 2022: US$ 267 Mn
Historical Data for: 2017 to 2020 Forecast Period: 2022 to 2030
Forecast Period 2022 to 2030 CAGR: 9.4 % 2030 Value Projection: US$ 547 Mn
Geographies covered:
  • North America: U.S. and Canada
  • Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
  • Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
  • Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
  • Middle East: GCC Countries, Israel, and Rest of Middle East
  • Africa: South Africa, North Africa, and Central Africa
Segments covered:
  • By Technology Type: Spatial Proteomics, Spatial Transcriptomics, Spatial Genomics
  • By Product Type: Instruments, Consumables, Software
  • By Workflow: Sample Preparation, Instrumental Analysis, Data Analysis
  • By Sample Type: FFPE, Fresh Frozen
  • By End User: Academics & Translational Research Institutes, Pharmaceutical & Biotechnology Companies
Companies covered:

10x Genomics, Akoya Bioscience Inc., Biognosys AG, BioSpyder Technologies, Bio-Techne, Bruker, Brooks Automation Inc., Danaher Corporation, Diagenode 

Growth Drivers:
  • With Increasing cancer population there is need of advanced technologies for the drug discovery and development.
  • With genomic and transcriptomics drug development process can be accelerated. 
Restraints & Challenges:
  • Limited research expertise are available.
  • Less skilled workforce. 

Figure 2. Global Spatial Omics Market Share (%), By Product Type, 2022

Spatial Omics  | Coherent Market Insights

The increasing product launches and approvals are expected to drive the market growth over the forecast period.

For instance, in August 2021, vizgen, the life science company dedicated to improving human health by visualizing single cell spatial genomics information has commercialized MERSCOPE platform, MERSCOPE is the only platform for MERFISH technology. MERFISH provides the highest detection efficacy available for spatially profiling gene expression across whole tissues and resolving individual transcripts with nanometre scale resolution through combinatorial labelling, sequential imaging, and error robust barcoding.

Moreover, in March 2021, Veranome Biosystems LLC, has revealed the world first complete sample to insight high plex spatial omics solution for single cell level characterization. The Pisces technology has been demonstrated to map thousands of custom gene panels in tissues at sub cellular resolution with high gene counts per cell and high sensitivity.

Global Spatial Omics Market – Impact of Coronavirus (Covid-19) Pandemic

Coronavirus (COVID-19) outbreak was first reported on December 31, 2019, in Wuhan, China. The World Health Organization declared COVID-19, as pandemic on March 11, 2020. According to the Coronavirus (COVID-19) Weekly Epidemiological Update by the World Health Organization, over 193,657,725 cases and 4,154,660 deaths due to coronavirus disease (COVID-19) were reported till July 25, 2021, across the globe.

Covid-19 did have negative impact on spatial omics market in early days of covid-19 spread, with decline in the company’s revenue in the second quarter of 2020, due to widespread customer lab closures due to lockdown. However, the impact did not last longer and company’s revenue increased gradually due to increase in consumables revenue driven by growth in instrument installed base.

For instance, the revenue of 10x Genomics of the fourth quarter of 2020 was 112.2 million with 49% increase in the revenue which was 75.3 in the third quarter.

Global Spatial Omics Market Restraint

Spatial omics is relatively new area of research, the global development of spatial transcriptomics research has been concentrated in the U.S and other developed countries. Moreover limited research expertise is available in this field and lack of skilled professionals. 

Key Players

Major players operating in the global spatial omics market include 10x Genomics, Akoya Bioscience Inc., Biognosys AG, BioSpyder Technologies, Bio-Techne, Bruker, Brooks Automation Inc., Danaher Corporation, Diagenode Diagnostics, Fluidigm Corporation, IonPath Inc., Millennium Science Pty Ltd, NanoString Technologies, PerkinElmer, Rebus Biosystems, Ultivue Inc., Vizgen Corp, Dovetail Genomics, S2 Genomics, Inc., Seven Bridges Genomics.

Spatial omics technologies have emerged during the last few years and have changed the way we understand multicellular biological systems, which includes genomics, transcriptomics, proteomics, and metabolomics.

Conventional proteomics and transcriptomics have provided granular insights into disease proliferation via identification of discrete cell population along with other pathological issues. Moreover, spatial omics methods provide high resolution mapping of expression profiles of cell tissues similar to that provided by mass spectrometry. Ability to retain spatial content of various cells in samples along with their cellular geometry and surrounding extracellular matrix (ECM) is likely to offer spatial omics with an opportunity to explore unexplored signal modalities.

Surge in acceptance of spatial genomics by start-ups and small firms along with its massive use in biomarker identification will drive the market, in addition to this, rise in application of spatial genomics in drug development and medicine discovery will create lucrative avenues for spatial omics industry.

Market Dynamics

The increasing population of cancers, rising research and development activities, and increasing adoption of inorganic growth strategies such as mergers, acquisitions, partnerships, and collaborations by key players operating in the market are the major factors that are expected to drive growth of the global spatial omics market over the forecast period.

According to American Cancer Society, in the U.S in 2022, about 99,780 new melanomas will be diagnosed (about 57,180 in men and 42,600 in women) and about 7,650 people are expected to die of melanoma (about 5,080 men and 2,570 women).

Key features of the study:

  • This report provides in-depth analysis of the global spatial omics market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2022–2030), considering 2021 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends,  regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global spatial omics market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include 10x Genomics, Akoya Bioscience Inc., Biognosys AG, BioSpyder Technologies, Bio-Techne, Bruker, Brooks Automation Inc., Danaher Corporation, Diagenode Diagnostics, Fluidigm Corporation, IonPath Inc., Millennium Science Pty Ltd, NanoString Technologies, PerkinElmer, Rebus Biosystems, Ultivue Inc., Vizgen Corp, Dovetail Genomics, S2 Genomics, Inc., Seven Bridges Genomics
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global spatial omics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global spatial omics market

Detailed Segmentation:

  • Global Spatial Omics Market, By Technology Type:
    • Spatial Proteomics
    • Spatial Transcriptomics
    • Spatial Genomics
  • Global Spatial Omics Market, By Product Type:
    • Instruments
    • Consumables
    • Software
  • Global Spatial Omics Market, By Workflow:
    • Sample Preparation
    • Instrumental Analysis
    • Data Analysis
  • Global Spatial Omics Market, By Sample Type:
    • FFPE
    • Fresh Frozen
  • Global Spatial Omics Market, By End User:
    • Academics & Translational Research Institutes
    • Pharmaceutical & Biotechnology Companies
  • Global Spatial Omics Market, By Region:
    • North America
      • By Country
        • U.S.
        • Canada
    • Latin America
      • By Country
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • By Country
        • Germany
        • U.K.
        • France
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • By Country
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • By Country
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • By Country/Region
        • South Africa
        • Central Africa
        • North Africa
  • Company Profiles
    • 10x Genomics.*
      • Company Overview
      • Material Portfolio
      • Financial Performance
      • Key Highlights
      • Market Strategies
    • Akoya Bioscience Inc
    • Biognosys AG
    • BioSpyder Technologies
    • Bio-Techne
    • Bruker
    • Brooks Automation Inc
    • Danaher Corporation
    • Diagenode Diagnostics
    • Fluidigm Corporation
    • IonPath Inc
    • Millennium Science Pty Ltd
    • NanoString Technologies
    • PerkinElmer
    • Rebus Biosystems
    • Ultivue Inc
    • Vizgen Corp
    • Dovetail Genomics
    • S2 Genomics, Inc
    • Seven Bridges Genomics

“*” marked represents similar segmentation in other categories in the respective section.

Frequently Asked Questions

The global spatial omics market size is estimated to be valued at US$ 267 million in 2021 and is expected to exhibit a CAGR of 9.4 % between 2021 and 2028.
Lately, spatial omics has shifted from strictly research application to drug discovery & development application. Genomics and transcriptomics are major tools for accelerating drug discovery and development processes. With the rapidly increasing global burden of cancer, there is a need for advanced technologies for drug discovery and development.
Spatial transcriptomics segment is expected to hold major market share, owing to launch of novel tools is expected to expand the transcriptomics study of single cell.
North America holds the largest market share in the market. 
Limited research expertise and lack of skilled workforce are hampering the growth of the market.
Major players operating in the market include 10x Genomics, Akoya Bioscience Inc., Biognosys AG, BioSpyder Technologies, Bio-Techne, Bruker, Brooks Automation Inc., Danaher Corporation, Diagenode Diagnostics, Fluidigm Corporation, IonPath Inc., Millennium Science Pty Ltd, NanoString Technologies, PerkinElmer, Rebus Biosystems, Ultivue Inc., Vizgen Corp, Dovetail Genomics, S2 Genomics, Inc., Seven Bridges Genomics.

Related Reports

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo